The Transformation of Germany’s Medical Cannabis Market: 2024 Brings Lower Prices, Higher Accessibility, and a Boom in Prescriptions

Germany’s medical cannabis market is undergoing a radical transformation in 2024, marked by lower prices, a surge in prescriptions, and a significant uptick in patient access. The catalyst? The reclassification of cannabis as a non-narcotic, which took effect on April 1, 2024. The shift has made medical cannabis more affordable and accessible, benefiting patients who are taking a more active role in their healthcare decisions. As prices plummet and variety expands, the future of medical cannabis in Germany is looking brighter than ever.

Lower Prices, Greater Access

According to Bloomwell GmbH, a Germany-based medical cannabis telehealth platform, the price of medical cannabis per gram dropped to an all-time low by the end of 2024. In fact, during October and November, select strains were available for just €3.99 per gram, a stark contrast to previous pricing models. This drop has been fueled by a steady supply and increased demand for medical cannabis, as the number of self-paying patients continues to soar.

While prices briefly rose after the reclassification in April 2024, they steadily declined throughout the year, making cannabis more affordable for everyday patients. In November 2024, the average price per gram was €8.35, down from €9.27 in January 2024. This price drop is not just a win for consumers; it’s a sign of the evolving cannabis market in Germany that is becoming more consumer-friendly, transparent, and sustainable.

Prescription Numbers Soar

Perhaps the most striking statistic from Bloomwell’s latest report is the explosive growth in the number of prescriptions. In December 2024, the number of prescriptions issued was up by more than 1,000 percent compared to March 2024, following the reclassification of cannabis. This indicates a huge jump in the number of self-paying patients, who are now able to access cannabis treatments for a variety of conditions—everything from chronic pain and insomnia to migraines and neuropathic disorders.

The rapid rise in prescriptions reflects the shifting perception of cannabis in Germany. What was once stigmatized is now recognized as a legitimate, medical treatment option, with both patients and healthcare professionals increasingly open to its potential.

A Booming Product Variety

Another significant change in 2024 has been the variety of medical cannabis products available in pharmacies. In just one year, the number of cannabis products dispensed by pharmacies has more than doubled. From oils and tinctures to vapes and edibles, patients now have more options than ever to tailor their treatments to their specific needs. As Bloomwell’s report shows, the diversity of cannabis products plays a critical role in making the therapy more adaptable and appealing to a wide range of patients, particularly those who may be exploring cannabis for the first time.

Digital Cannabis Revolution

The expansion of digital healthcare platforms has also played a crucial role in this medical cannabis renaissance. Bloomwell, for instance, has spearheaded the integration of telemedicine into the cannabis industry. By offering remote consultations and e-prescriptions, Bloomwell has made it easier for patients to access medical cannabis treatments, bypassing the inefficiencies and delays often associated with traditional healthcare systems. This digital-first approach has proven to be particularly beneficial in a country like Germany, where bureaucracy and logistical hurdles can often hinder patient care.

The Impact on Germany’s Economy

As cannabis becomes more accessible, its economic impact is being felt across Germany. Niklas Kouparanis, Co-Founder and CEO of Bloomwell Group, sees the shift as a major turning point for both the healthcare and economic landscape of the country. He highlights that the legalization of medical cannabis could serve as a model for other European nations, ushering in a new era of progressive policy and innovation. With more patients, more prescriptions, and lower costs, the German cannabis market is poised for continued growth—creating jobs, driving investments, and enhancing the country’s healthcare infrastructure.

“The reclassification of cannabis has sparked a new era in Germany’s medical cannabis industry,” Kouparanis says. “Despite the rapid increase in cannabis patients, we’ve ensured a secure supply while continuing to innovate and expand access for patients. The real challenge now is for the incoming government to foster an environment where innovation can thrive and patients can continue to benefit from affordable and accessible cannabis therapy.”

A Bright Future for Patients

For patients, the future of medical cannabis in Germany is incredibly promising. As more research emerges about the therapeutic benefits of cannabis, and as digital platforms like Bloomwell make treatment more accessible, patients are increasingly turning to cannabis as a safe and effective alternative to conventional medications.

According to Dr. Julian Wichmann, Co-Founder and CEO of Bloomwell GmbH, the medical use of cannabis is far less risky than many traditional pharmaceuticals. “Medical cannabis typically has milder side effects than many medications used to treat common conditions like sleep disorders, chronic pain, and migraines. It can also be a sensible alternative to treat conditions that currently lack other forms of prescription medications,” he explains.

In an era where self-care and patient autonomy are more important than ever, Germany’s medical cannabis revolution represents a significant step forward. For both patients and healthcare professionals, the ability to access safe, regulated cannabis through telemedicine is changing the way healthcare is delivered, making it easier, faster, and more affordable than ever before.

Looking Ahead: The Future of Cannabis in Germany

With a booming market and increasing public acceptance, Germany’s medical cannabis industry is entering a new chapter. As the country leads Europe in cannabis policy reform, the impact on both public health and the economy is becoming undeniable. The next few years will undoubtedly see continued growth in both the supply and demand for medical cannabis, with digital platforms like Bloomwell playing a key role in shaping the future of this rapidly expanding sector.

For now, patients can celebrate the benefits of lower prices, greater product variety, and faster access to medical cannabis. As for Germany, it seems clear that the cannabis revolution is only just beginning.